Patient-Reported Outcomes in Myelodysplastic Syndromes and MDS/MPN Overlap Syndromes: Stepping Onto the Stage with Changing Times (Q88810045)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28822056%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

title

Patient-Reported Outcomes in Myelodysplastic Syndromes and MDS/MPN Overlap Syndromes: Stepping Onto the Stage with Changing Times (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28822056%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28822056%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Aaron T Gerds

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28822056%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

publication date

1 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28822056%20AND%20SRC:MED&resulttype=core&format=json

Current hematologic malignancy reports

27 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28822056%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28822056%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28822056%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

page(s)

455-460

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28822056%20AND%20SRC:MED&resulttype=core&format=json

Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial

27 March 2020

cites work

1 reference

12 December 2020

JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis

1 reference

12 December 2020

Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis

1 reference

12 December 2020

1 reference

12 December 2020

Developing a valid patient-reported outcome measure

1 reference

12 December 2020

The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients.

1 reference

12 December 2020

The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients.

1 reference

12 December 2020

Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes

1 reference

12 December 2020

An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults

1 reference

12 December 2020

Patient-reported outcomes for acute graft-versus-host disease prevention and treatment trials

1 reference

12 December 2020

Screening for mental health: validity of the MHI-5 using DSM-IV Axis I psychiatric disorders as gold standard.

1 reference

12 December 2020

The MOS social support survey

1 reference

12 December 2020

Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS).

1 reference

12 December 2020

Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale.

1 reference

12 December 2020

The effect of palliative care on patient functioning

1 reference

12 December 2020

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

12 December 2020

Comparison between patient-reported and clinician-observed symptoms in oncology

1 reference

12 December 2020

1 reference

12 December 2020

Development and validation of a scale to measure symptoms of chronic graft-versus-host disease

1 reference

12 December 2020

The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008.

1 reference

12 December 2020

The timed "Up & Go": a test of basic functional mobility for frail elderly persons

1 reference

12 December 2020

Early palliative care for patients with metastatic non-small-cell lung cancer

1 reference

12 December 2020

Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008.

1 reference

12 December 2020

Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer

1 reference

12 December 2020

Quality of life and social support of patients being evaluated for bone marrow transplantation

1 reference

12 December 2020

A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis

1 reference

12 December 2020

Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial

1 reference

12 December 2020

Assessment of older people: self-maintaining and instrumental activities of daily living

1 reference

12 December 2020

Does this patient have dementia?

1 reference

12 December 2020

Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

1 reference

12 December 2020

Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001.

1 reference

12 December 2020

Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome

1 reference

12 December 2020

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report.

1 reference

12 December 2020

The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire

1 reference

12 December 2020

Outcome of transplantation for myelofibrosis

1 reference

12 December 2020

Low-dose decitabine versus best supportive care in elderly patients with intermediate- or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final results of the randomized phase III study of the European Organisation fo

1 reference

12 December 2020

Patient-reported outcomes for the myelodysplastic syndromes: a new MDS-specific measure of quality of life.

1 reference

12 December 2020

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance

1 reference

12 December 2020

The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation

1 reference

12 December 2020

10.1007/S11899-017-0406-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28822056%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

1 reference